E
LHDX

Ergoteles’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Ergoteles’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,331
Closed -$117K – 1720
2021
Q3 		$117K Sell
15,331
-27,167
-64% -$229K ﹤0.01% 1081
2021
Q2 		$282K Buy
+42,498
New +$268K 0.01% 1104

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

Ergoteles's LHDX Position: Q4 2021 in Review

Ergoteles sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2021, closing a stake of 15,331 shares — an estimated $117K sold.

Ergoteles first reported a position in LHDX in Q2 2021 and held it in 2 quarters. The position peaked at $282K in Q2 2021. 46 funds tracked by Wall St. Rank hold LHDX as of Q4 2021.

  • Ergoteles reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 15,331 Lucira Health, Inc. Common Stock shares in Q4 2021, an estimated $117K.
  • Ergoteles first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Ergoteles's Lucira Health, Inc. Common Stock position peaked at $282K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.